Skip to main content
NCBI home page
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 1992 Dec;84(12):1025–1029.

Drug resistance in malaria: a review of the west African situation.

K O Adubofour 1
PMCID: PMC2571656  PMID: 1296994

Abstract

Chloroquine-resistant Plasmodium falciparum malaria is an emerging problem in the West African subregion. While chloroquine remains an effective antimalarial agent in some countries of West Africa, the susceptibility patterns of P falciparum strains need to be assessed periodically. This article reviews the literature on chloroquine-resistant P falciparum malaria.

Full text

PDF
1025

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aderounmu A. F., Salako L. A., Adelusi S. A. Chloroquine sensitivity of Plasmodium falciparum in Ibadan, Nigeria. Trans R Soc Trop Med Hyg. 1980;74(3):393–395. doi: 10.1016/0035-9203(80)90108-x. [DOI] [PubMed] [Google Scholar]
  2. Allen S. J., Otoo L. N., Cooke G. A., O'Donnell A., Greenwood B. M. Sensitivity of Plasmodium falciparum to chlorproguanil in Gambian children after five years of continuous chemoprophylaxis. Trans R Soc Trop Med Hyg. 1990 Mar-Apr;84(2):218–218. doi: 10.1016/0035-9203(90)90261-c. [DOI] [PubMed] [Google Scholar]
  3. Björkman A., Willcox M. In vitro susceptibility of Plasmodium falciparum to amodiaquine, mefloquine, quinine and chloroquine in Liberia, West Africa. Trans R Soc Trop Med Hyg. 1986;80(5):761–762. doi: 10.1016/0035-9203(86)90379-2. [DOI] [PubMed] [Google Scholar]
  4. Björkman A., Willcox M. In vivo and in vitro susceptibility of Plasmodium falciparum to sulphadoxine/pyrimethamine in Liberia, West Africa. Trans R Soc Trop Med Hyg. 1986;80(4):572–574. doi: 10.1016/0035-9203(86)90144-6. [DOI] [PubMed] [Google Scholar]
  5. Chippaux J. P., Massougbodji A., Olliaro P., Gay F., Caligaris S., Danis M. Sensitivity in vitro of Plasmodium falciparum to chloroquine and mefloquine in two regions of Benin. Trans R Soc Trop Med Hyg. 1989 Sep-Oct;83(5):584–585. doi: 10.1016/0035-9203(89)90359-3. [DOI] [PubMed] [Google Scholar]
  6. Clarke E. A., Anderson T. W. Does screening by "Pap" smears help prevent cervical cancer? A case-control study. Lancet. 1979 Jul 7;2(8132):1–4. doi: 10.1016/s0140-6736(79)90172-7. [DOI] [PubMed] [Google Scholar]
  7. Daniel H. I., Molta N. B. Efficacy of chloroquine in the treatment of malaria in children under five years in Baissa (Gongola State, Nigeria). Ann Trop Med Parasitol. 1989 Aug;83(4):331–338. doi: 10.1080/00034983.1989.11812353. [DOI] [PubMed] [Google Scholar]
  8. Draper C. C., Brubaker G., Geser A., Kilimali V. A., Wernsdorfer W. H. Serial studies on the evolution of chloroquine resistance in an area of East Africa receiving intermittent malaria chemosuppression. Bull World Health Organ. 1985;63(1):109–118. [PMC free article] [PubMed] [Google Scholar]
  9. Fadeke Aderounmu A., Salako L. A., Laoye A. J., Modupe Makinde J., Aina Adio R. Comparison of the susceptibility of falciparum malaria to mefloquine-sulphadoxine-pyrimethamine and chloroquine in Nigeria. Afr J Med Med Sci. 1988 Dec;17(4):195–200. [PubMed] [Google Scholar]
  10. Gbary A. R., Guiguemdé T. R., Ouedraogo J. B. Emergence du paludisme chloroquinoresistant en Afrique de l'Ouest: cas de Sokodé (Togo). Trop Med Parasitol. 1988 Jun;39(2):142–144. [PubMed] [Google Scholar]
  11. Hogerzeil H. V., Hogewoning A. A., van Doorn J. W., Wernsdorfer W. H., van der Kaay H. J. In vitro assessment of sensitivity of Plasmodium falciparum to chloroquine and mefloquine in Ghana. Trans R Soc Trop Med Hyg. 1985;79(6):808–811. doi: 10.1016/0035-9203(85)90126-9. [DOI] [PubMed] [Google Scholar]
  12. Lavoue V., Lavoue P., Turk P., Brasseur P., Druilhe P. Low prevalence of P. falciparum in-vivo resistance to chloroquine in northern Cameroon in 1986. Trop Med Parasitol. 1988 Sep;39(3):249–250. [PubMed] [Google Scholar]
  13. Lege-Oguntoye L., Abua J. U., Werblinska B., Ogala W. N., Slotboom A. B., Olurinola P. F. Chloroquine resistance of Plasmodium falciparum in semi-immune children in Zaria, northern Nigeria. Trans R Soc Trop Med Hyg. 1989 Sep-Oct;83(5):599–601. doi: 10.1016/0035-9203(89)90366-0. [DOI] [PubMed] [Google Scholar]
  14. Lindberg J., Sandberg T., Björkholm B., Björkman A. Chloroquine and Fansidar resistant malaria acquired in Angola. Lancet. 1985 Mar 30;1(8431):765–765. doi: 10.1016/s0140-6736(85)91315-7. [DOI] [PubMed] [Google Scholar]
  15. Lucas A. O., Hendrickse R. G., Okubadejo O. A., Richards W. H., Neal R. A., Kofie B. A. The suppression of malarial parasitaemia by pyrimethamine in combination with dapsone or sulphormethoxine. Trans R Soc Trop Med Hyg. 1969;63(2):216–229. doi: 10.1016/0035-9203(69)90150-3. [DOI] [PubMed] [Google Scholar]
  16. Malin A. S., Hall A. P. Falciparum malaria resistant to quinine and pyrimethamine-sulfadoxine successfully treated with mefloquine. BMJ. 1990 May 5;300(6733):1175–1175. doi: 10.1136/bmj.300.6733.1175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Nguyen C., Gregson D., Mouldey P., Keystone J. S. Falciparum malaria resistant to chloroquine, quinine and Fansidar in a non-immune patient infected in Ghana. Trans R Soc Trop Med Hyg. 1989 Jul-Aug;83(4):485–486. doi: 10.1016/0035-9203(89)90258-7. [DOI] [PubMed] [Google Scholar]
  18. Oduola A. M., Milhous W. K., Salako L. A., Walker O., Desjardins R. E. Reduced in-vitro susceptibility to mefloquine in West African isolates of Plasmodium falciparum. Lancet. 1987 Dec 5;2(8571):1304–1305. doi: 10.1016/s0140-6736(87)91195-0. [DOI] [PubMed] [Google Scholar]
  19. Ofori-Adjei D., Commey J. O., Adjepon-Yamoah K. K. Serum chloroquine levels in children before treatment for malaria. Lancet. 1984 Jun 2;1(8388):1246–1246. doi: 10.1016/s0140-6736(84)91736-7. [DOI] [PubMed] [Google Scholar]
  20. Olatunde A., Salako L. A., Walker O. The in vivo sensitivity of Plasmodium falciparum to chloroquine and to sulphadoxine-pyrimethamine combination in Ibadan, Nigeria. Trans R Soc Trop Med Hyg. 1981;75(6):848–850. doi: 10.1016/0035-9203(81)90429-6. [DOI] [PubMed] [Google Scholar]
  21. Rieckmann K. H., Campbell G. H., Sax L. J., Mrema J. E. Drug sensitivity of plasmodium falciparum. An in-vitro microtechnique. Lancet. 1978 Jan 7;1(8054):22–23. doi: 10.1016/s0140-6736(78)90365-3. [DOI] [PubMed] [Google Scholar]
  22. Rønne T. Measles virus infection without rash in childhood is related to disease in adult life. Lancet. 1985 Jan 5;1(8419):1–5. doi: 10.1016/s0140-6736(85)90961-4. [DOI] [PubMed] [Google Scholar]
  23. Salako L. A., Sowunmi A., Laoye O. J. Evaluation of the sensitivity in vivo and in vitro of Plasmodium falciparum malaria to quinine in an area of full sensitivity to chloroquine. Trans R Soc Trop Med Hyg. 1988;82(3):366–368. doi: 10.1016/0035-9203(88)90120-4. [DOI] [PubMed] [Google Scholar]
  24. Simooya O. O., Aderounmu A. F., Salako L. A. Sensitivity of Plasmodium falciparum to chloroquine, amodiaquine and mefloquine in Ibadan, Nigeria. Afr J Med Med Sci. 1988 Mar;17(1):3–7. [PubMed] [Google Scholar]
  25. Tin F., Hlaing N., Tun T., Win S., Lasserre R. Falciparum malaria treated with a fixed combination of mefloquine, sulfadoxine and pyrimethamine: a field study in adults in Burma. Bull World Health Organ. 1985;63(4):727–730. [PMC free article] [PubMed] [Google Scholar]
  26. Verdrager J. Epidemiology of the emergence and spread of drug-resistant falciparum malaria in South-East Asia and Australasia. J Trop Med Hyg. 1986 Dec;89(6):277–289. [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES